CRIS Current Research Information System

CIANI, ELISABETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.852
EU - Europa 2.922
AS - Asia 764
AF - Africa 254
SA - Sud America 11
OC - Oceania 2
Totale 7.805
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.842
IT - Italia 974
GB - Regno Unito 647
DE - Germania 364
SE - Svezia 281
CN - Cina 269
VN - Vietnam 241
IN - India 141
TG - Togo 134
IE - Irlanda 113
UA - Ucraina 112
FR - Francia 95
CH - Svizzera 70
RU - Federazione Russa 67
BG - Bulgaria 49
JO - Giordania 47
ZA - Sudafrica 47
EE - Estonia 40
NG - Nigeria 32
BE - Belgio 28
CI - Costa d'Avorio 26
ES - Italia 19
FI - Finlandia 14
IR - Iran 13
JP - Giappone 12
SC - Seychelles 12
CA - Canada 10
NL - Olanda 10
GR - Grecia 9
TR - Turchia 9
AT - Austria 8
HK - Hong Kong 8
HR - Croazia 7
BR - Brasile 6
PL - Polonia 5
AE - Emirati Arabi Uniti 4
DK - Danimarca 4
LB - Libano 3
PE - Perù 3
RO - Romania 3
SG - Singapore 3
AU - Australia 2
CL - Cile 2
IL - Israele 2
MA - Marocco 2
MY - Malesia 2
PH - Filippine 2
PK - Pakistan 2
SA - Arabia Saudita 2
BD - Bangladesh 1
ID - Indonesia 1
KR - Corea 1
LK - Sri Lanka 1
NO - Norvegia 1
SK - Slovacchia (Repubblica Slovacca) 1
SM - San Marino 1
TN - Tunisia 1
Totale 7.805
Salva come PNG Salva come JPEG
Città #
Chandler 543
Southend 504
Fairfield 503
Bologna 387
Ashburn 305
Houston 251
Wilmington 234
Woodbridge 227
Ann Arbor 210
Seattle 209
Cambridge 185
Dong Ket 144
Princeton 137
Lomé 134
Dublin 113
Jacksonville 71
Bern 65
Turin 59
Westminster 55
Nanjing 54
Bristol 53
Padova 52
Falls Church 50
Berlin 49
Sofia 49
Amman 47
Redmond 47
Frankfurt am Main 36
San Diego 36
Trento 36
Marano 34
Beijing 33
Abeokuta 31
Islington 29
New York 28
Brussels 27
Milan 27
Abidjan 26
Shenyang 26
Argelato 23
Saint Petersburg 23
Changsha 21
Jinan 19
Mülheim 17
Dearborn 15
Hebei 15
Jerez De La Frontera 15
Nanchang 15
Redwood City 15
Boardman 14
Pune 14
Rome 14
Bolzano 13
Bremen 13
Helsinki 13
Des Moines 12
Mahé 11
Paris 11
Tianjin 11
Florence 10
Medford 10
Norwalk 9
Taizhou 9
Toronto 9
Forlì 8
Haikou 8
Verona 8
Amsterdam 7
Bari 7
Hangzhou 7
Modena 7
Ardabil 6
Boydton 6
Los Angeles 6
Monmouth Junction 6
Olalla 6
Ravenna 6
Tokyo 6
Vienna 6
Gagliano del Capo 5
Istanbul 5
Jiaxing 5
Lanzhou 5
Leawood 5
London 5
Mountain View 5
Ningbo 5
Phoenix 5
Piacenza 5
Aldenhoven 4
Bengaluru 4
Bentivoglio 4
Bondeno 4
Bühl 4
Castenaso 4
Chicago 4
Formigine 4
Fort Collins 4
Frankfurt Am Main 4
Fremont 4
Totale 5.651
Salva come PNG Salva come JPEG
Nome #
CDKL5 protein substitution therapy rescues neurological phenotypes of a mouse model of CDKL5 disorder 219
Inhibition of microglia over-activation restores neuronal survival and maturation in a mouse model of CDKL5 deficiency disorder 184
CDKL5 deficiency entails sleep apneas in mice 177
CDKL5 deficiency predisposes neurons to cell death through the deregulation of SMAD3 signaling (vol 29, pg 658, 2019) 173
Age-related impairment of olfactory bulb neurogenesis in the Ts65Dn mouse model of Down syndrome 160
Heterozygous CDKL5 Knockout Female Mice Are a Valuable Animal Model for CDKL5 Disorder 154
Functional impairments in the perirhinal cortex of a mouse model of CDKL5 deficiency disorder are ameliorated by a GABAB receptor antagonist 149
Characterization of Perinatal Stem Cell Spheroids for the Development of Cell Therapy Strategy 148
HDAC4: a key factor underlying brain developmental alterations in CDKL5 disorder 145
Dietary restriction differentially protects from neurodegeneration in animal models of excitotoxicity. 144
CDKL5, a novel MYCN-repressed gene, blocks cell cycle and promotes differentiation of neuronal cells 143
The amyloid precursor protein (APP) triplicated gene impairs neuronal precursor differentiation and neurite development through two different domains in the Ts65Dn mouse model for down syndrome. 143
APP-dependent alteration of GSK3β activity impairs neurogenesis in the Ts65Dn mouse model of Down syndrome. 142
Early Pharmacotherapy with Fluoxetine Rescues Dendritic Pathology in the Ts65Dn Mouse Model of Down Syndrome 139
Lithium Restores Age Related Olfactory Impairment in the Ts65Dn Mouse Model of Down Syndrome 132
Inhibition of GSK3β rescues hippocampal development and learning in a mouse model of CDKL5 disorder 131
Cell cycle alteration and decreased cell proliferation in the hippocampal dentate gyrus and in the neocortical germinal matrix of fetuses with Down syndrome and in Ts65Dn mice 131
A GABAB receptor antagonist rescues functional and structural impairments in the perirhinal cortex of a mouse model of CDKL5 deficiency disorder 131
Neurochemical correlates of nicotine neurotoxicity on rat habenulo-interpeduncular cholinergic neurons. 130
null 130
Widespread impairment of cell proliferation in the neonate Ts65Dn mouse, a model for Down syndrome. 129
APP-dependent up-regulation of Ptch1 underlies proliferation impairment of neural precursors in Down syndrome. 129
Age-related cognitive and motor decline in a mouse model of CDKL5 deficiency disorder is associated with increased neuronal senescence and death 129
Treatment with the GSK3-beta inhibitor Tideglusib improves hippocampal development and memory performance in juvenile, but not adult, Cdkl5 knockout mice 128
Cell cycle elongation impairs proliferation of cerebellar granule cell precursors in the Ts65Dn Mouse, an animal model for Down syndrome. 127
Long-term effect of neonatal inhibition of APP gamma-secretase on hippocampal development in the Ts65Dn mouse model of Down syndrome 126
Postnatal neurogenesis in the dentate gyrus of the guinea pig 124
Cyclic AMP-mediated regulation of transcription factor Lot1 expression in cerebellar granule cells. 122
Epigallocatechin gallate: A useful therapy for cognitive disability in Down syndrome? 119
Choline acetyltransferase activity at different ages in brain of Ts65Dn mice, an animal model for Down's syndrome and related neurodegenerative diseases. 115
Functional and structural impairments in the perirhinal cortex of a mouse model of CDKL5 deficiency disorder are rescued by a TrkB agonist 115
Sex differences in the stereological parameters of the hippocampal dentate gyrus of the guinea pig before puberty 114
Early-occurring proliferation defects in peripheral tissues of the Ts65Dn mouse model of Down syndrome are associated with patched1 over expression 113
Early Pharmacotherapy Restores Neurogenesis and Cognitive Performance in the Ts65Dn Mouse Model for Down Syndrome 112
Inhibition of APP gamma-secretase restores Sonic Hedgehog signaling and neurogenesis in the Ts65Dn mouse model of Down syndrome 112
CB1 cannabinoid receptors increase neuronal precursor proliferation through AKT/GSK-3{beta}/{beta}-catenin signaling 109
Effect of early isolation on signal transfer in the entorhinal cortex-dentate-hippocampal system 108
Mapping pathological phenotypes in a mouse model of CDKL5 disorder. 108
Timing of therapies for downsyndrome: The sooner, the better 106
Loss of CDKL5 impairs survival and dendritic growth of newborn neurons by altering AKT/GSK-3β signaling. 105
Impact of environmental enrichment on neurogenesis in the dentate gyrus during the early postnatal period. 104
Luteolin Treatment Ameliorates Brain Development and Behavioral Performance in a Mouse Model of CDKL5 Deficiency Disorder 103
Pharmacotherapy with Fluoxetine Restores Functional Connectivity from the Dentate Gyrus to Field CA3 in the Ts65Dn Mouse Model of Down Syndrome 103
Widespread proliferation impairment and hypocellularity in the cerebellum of fetuses with Down syndrome. 101
null 100
Proliferation of cerebellar precursor cells is negatively regulated by nitric oxide in newborn rat. 99
Pharmacotherapy with sertraline rescues brain development and behavior in a mouse model of CDKL5 deficiency disorder 99
The place of choline acetyltransferase activity measurement in the "cholinergic hypothesis" of neurodegenerative diseases 98
null 97
Nitric oxide negatively regulates proliferation and promotes neuronal differentiation through N-Myc downregulation. 95
Is it possible to improve neurodevelopmental abnormalities in Down syndrome? 95
Sex differences in the hilar mossy cells of the guinea-pig before puberty. 94
Lot1 is a key element of the pituitary adenylate cyclase-activating polypeptide (PACAP)/cyclic AMP pathway that negatively regulates neuronal precursor proliferation. 92
Treatment with a GSK-3β/HDAC Dual Inhibitor Restores Neuronal Survival and Maturation in an In Vitro and In Vivo Model of CDKL5 Deficiency Disorder 92
Inhibition of microglia overactivation restores neuronal survival in a mouse model of CDKL5 deficiency disorder 92
Prenatal pharmacotherapy rescues brain development in a Down's syndrome mouse model. 90
Increased DNA Damage and Apoptosis in CDKL5-Deficient Neurons 90
Role of nitric oxide in the regulation of neuronal proliferation, survival and differentiation. 89
Expression of a Secretable, Cell-Penetrating CDKL5 Protein Enhances the Efficacy of Gene Therapy for CDKL5 Deficiency Disorder 86
Updating the dual role of brain nitric oxide in neurodegeneration/neuroprotection: understanding molecular mechanisms to devise drug approaches. 86
The green tea polyphenol epigallocatechin-3-gallate (EGCG) restores CDKL5-dependent synaptic defects in vitro and in vivo 83
Neurogenesis impairment and increased cell death reduce total neuron number in the hippocampal region of fetuses with Down syndrome 75
Neonatal isolation impairs neurogenesis in the dentate gyrus of the guinea pig. 73
Cardiac Functional and Structural Abnormalities in a Mouse Model of CDKL5 Deficiency Disorder 68
TATK-CDKL5 FUSION PROTEINS, COMPOSITIONS, FORMULATIONS, AND USE THEREOF 68
Site-specific abnormalities in the visual system of a mouse model of CDKL5 deficiency disorder 64
Treatment with FRAX486 rescues neurobehavioral and metabolic alterations in a female mouse model of CDKL5 deficiency disorder 47
Short- and long-term effects of neonatal pharmacotherapy with epigallocatechin-3-gallate on hippocampal development in the Ts65Dn mouse model of Down syndrome 40
Lithium restores neurogenesis in the subventricular zone of the Ts65Dn mouse, a model for Down sindrome 38
Artificial protein and its applications 37
Long-term effects of neonatal treatment with fluoxetine on cognitive performance in Ts65Dn mice. 32
Early-onset brain alterations during postnatal development in a mouse model of CDKL5 deficiency disorder 29
Heterozygous CDKL5 Knockout Female Mice Are a Valuable Animal Model for CDKL5 Disorder 22
Sex differences in the hippocampal dentate gyrus of the guinea-pig before puberty 14
Effects of gestational or neonatal treatment with alpha-difluoromethylornithine on ornithine decarboxylase and polyamines in developing rat brain and on adult rat neurochemistry 14
Voluntary Running Improves Behavioral and Structural Abnormalities in a Mouse Model of CDKL5 Deficiency Disorder 11
Sex differences in the hilar mossy cells of the guinea-pig before puberty 4
Nitric oxide regulates cGMP-dependent cAMP-responsive element binding protein phosphorylation and Bcl-2 expression in cerebellar neurons: Implication for a survival role of nitric oxide 3
Totale 7.982
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.805
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.805
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201981 0 0 0 0 0 0 0 0 0 0 37 44
2019/20201.869 234 37 21 108 187 201 228 259 282 121 94 97
2020/20211.139 178 91 36 50 30 96 12 63 90 98 53 342
2021/20221.475 99 71 117 117 135 102 62 80 71 107 261 253
2022/20232.213 173 366 105 260 162 196 55 125 365 51 166 189
2023/2024729 58 83 37 85 49 135 88 70 50 40 34 0
Totale 7.982